{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:40:04Z","timestamp":1756316404113,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,6,3]]},"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>A 72-year-old woman was admitted to the hospital because of dorsal, lumbar and lower abdomen pain that had started 4 days before. She had a history of age-related macular degeneration (treated with intraocular bevacizumab). Blood tests showed anaemia, thrombocytopaenia, acute kidney injury, elevated liver enzymes and total bilirubin (mainly because of the indirect fraction). Viral serologies and ADAMTS13 activity levels were normal, and stool testing was negative for <jats:italic>Escherichia coli<\/jats:italic>-producing Shiga toxins. <jats:italic>E. coli<\/jats:italic> was isolated in urine. Atypical haemolytic uremic syndrome triggered by a urinary tract infection or by the vascular endothelial growth factor-inhibitor bevacizumab were the most likely hypothesis. The patient started urgent plasmapheresis and dialysis that lasted for a total of 18 days. There was complete remission and recovery of kidney function allowing for treatment discontinuation, and she was discharged home. After 6 months of follow-up, she shows no signs of relapse.<\/jats:p>","DOI":"10.1136\/bcr-2019-230026","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T05:35:22Z","timestamp":1561700122000},"page":"e230026","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Atypical haemolytic uremic syndrome from multiple missenses to a full-blown disease"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5682-3116","authenticated-orcid":false,"given":"Filipe Santos","family":"Mira","sequence":"first","affiliation":[{"name":"Nephrology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"},{"name":"Nephrology, Faculty of Medicine, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Lu\u00edsa","family":"Nunes","sequence":"additional","affiliation":[{"name":"Internal Medicine, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Rita","family":"Elvas","sequence":"additional","affiliation":[{"name":"Internal Medicine, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Nephrology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"},{"name":"Nephrology, Faculty of Medicine, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,6,27]]},"reference":[{"key":"2025082710215564000_12.6.e230026.1","first-page":"211","article-title":"Portuguese consensus document statement in diagnosis and management of atypical hemolytic uremic syndrome","volume":"32","author":"Azevedo","year":"2018","journal-title":"PJNH"},{"key":"2025082710215564000_12.6.e230026.2","first-page":"27","article-title":"Actualizaci\u00f3n en s\u00edndrome hemol\u00edtico ur\u00e9mico at\u00edpico: diagn\u00f3stico y tratamiento","volume":"33","author":"Campistol","year":"2013","journal-title":"Documento de consenso Nefrolog\u00eda"},{"key":"2025082710215564000_12.6.e230026.3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00620117"},{"key":"2025082710215564000_12.6.e230026.4","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-014-1655-2"},{"key":"2025082710215564000_12.6.e230026.5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/rth2.12016","article-title":"Combined study of ADAMTS13 and complement genes in the diagnosis of thrombotic microangiopathies using next-generation sequencing","volume":"1","author":"Fidalgo","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"2025082710215564000_12.6.e230026.6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nefro.2015.07.005","article-title":"\u201cAn update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document\u201d","volume":"35","author":"Campistol","year":"2015","journal-title":"Nefrolog\u00eda"},{"key":"2025082710215564000_12.6.e230026.7","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.11.030"},{"key":"2025082710215564000_12.6.e230026.8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.nefro.2017.01.006","article-title":"Secondary thrombotic microangiopathy and eculizumab: a reasonable therapeutic option","volume":"37","author":"Rom\u00e1n","year":"2017","journal-title":"Nefrologia"},{"key":"2025082710215564000_12.6.e230026.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707330"},{"key":"2025082710215564000_12.6.e230026.10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000333"},{"key":"2025082710215564000_12.6.e230026.11","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfn168"},{"key":"2025082710215564000_12.6.e230026.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.06.014"},{"key":"2025082710215564000_12.6.e230026.13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1109557"},{"key":"2025082710215564000_12.6.e230026.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2016.11.016"},{"key":"2025082710215564000_12.6.e230026.15","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-17432"},{"key":"2025082710215564000_12.6.e230026.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.10.005"},{"key":"2025082710215564000_12.6.e230026.17","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.12.034"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-230026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:22:03Z","timestamp":1756315323000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-230026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":17,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,27]]},"published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1136\/bcr-2019-230026"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-230026","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}